ID   SCC13-MET-KOc1-8
AC   CVCL_D2XP
DR   Wikidata; Q127384187
RX   PubMed=34593609;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4029 ! SCC-13
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   PubMed=34593609; DOI=10.1158/1541-7786.MCR-21-0306; PMCID=PMC10088464;
RA   Chen X., Adhikary G., Shrestha S., Xu W., Keillor J.W., Naselsky W.,
RA   Eckert R.L.;
RT   "Transglutaminase 2 maintains hepatocyte growth factor signaling to
RT   enhance the cancer cell phenotype.";
RL   Mol. Cancer Res. 19:2026-2035(2021).
//